サンプル依頼リスト カート
  • English
  • Korean
表紙：咽頭炎治療の世界市場レポート 2024年
市場調査レポート
商品コード
1415684

咽頭炎治療の世界市場レポート 2024年

Pharyngitis Treatment Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
咽頭炎治療の世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

咽頭炎治療の市場規模は近年力強く成長しています。2023年の21億5,000万米ドルから2024年には22億7,000万米ドルに、CAGR5.5％で成長します。実績期間の成長は、インフルエンザの高い有病率と罹患率の増加、咽頭炎の有病率の上昇、咽頭炎に対する意識の高まり、医療へのアクセスの増加、可処分所得の上昇に起因しています。

咽頭炎治療市場規模は、今後数年間で力強い成長が見込まれます。2028年にはCAGR5.3％で28億米ドルに成長します。予測期間の成長は、迅速なポイントオブケア検査の採用、個別化医療の需要、抗生物質耐性の蔓延、手指衛生の重要性の高まりに起因します。予測期間の主要動向には、咽頭炎治療薬の研究開発の進展、デジタルヘルス技術、遠隔医療統合、咽頭炎治療薬の研究開発などがあります。

溶連菌感染症の増加は、咽頭炎治療市場の拡大を促進します。溶連菌感染症は、主に咽頭と扁桃腺を侵す伝染性の細菌感染症です。抗生物質による溶連菌感染症の迅速かつ効果的な治療は、症状の緩和、合併症の予防、他者への感染リスクの低減のために極めて重要です。例えば、2022年6月現在、米国の政府機関である疾病対策予防センターのデータによると、米国では侵襲性A群溶連菌感染症が年間約1万4,000～2万5,000件発生しています。さらに、溶連菌関連疾患は毎年520万人の外来受診を促し、280万人の抗生物質処方をもたらしています。このように、溶連菌感染症の増加は咽頭炎治療市場の成長促進要因となっています。

インフルエンザの流行増加は、咽頭炎治療市場の拡大を促進すると予測されています。一般的にインフルエンザと呼ばれるインフルエンザは、インフルエンザウイルスによって引き起こされる伝染性の呼吸器疾患です。咽頭炎治療は、喉の炎症や炎症などの症状を緩和し、肺炎や気管支炎などの合併症を予防しながらアレルギーを管理することに重点を置き、インフルエンザに対処する上で極めて重要な役割を果たしています。例えば、米国の政府機関である疾病対策予防センター（CDC）が2023年5月に発表したデータによると、米国では2021年から2022年にかけて900万人のインフルエンザ患者が発生し、5,000人が死亡したと記録されています。その結果、インフルエンザ罹患率の増加が咽頭炎治療市場の成長促進要因となっています。

2023年の咽頭炎治療市場では北米が最大地域でした。アジア太平洋は予測期間中に最も急成長する地域となる見込みです。咽頭炎治療レポートの対象地域は、アジア太平洋、西欧、中東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の咽頭炎治療市場の促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の咽頭炎治療市場規模実績と成長、2018～2023年
  • 世界の咽頭炎治療市場規模と成長予測、2023～2028年、2033年

第6章 市場セグメンテーション

  • 世界の咽頭炎治療市場、薬剤クラス別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
  • ベータラクタム
  • マクロライド系
  • セファロスポリン類
  • フルオロキノロン類
  • テトラサイクリン
  • その他の薬剤クラス
  • 世界の咽頭炎治療市場、感染源別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
  • ウイルス性
  • 細菌性
  • 世界の咽頭炎治療市場、提供方法別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
  • 経口
  • 静脈内
  • 筋肉内
  • その他の提供方法
  • 世界の咽頭炎治療市場、エンドユーザー別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
  • 病院
  • 在宅医療
  • 専門センター
  • その他のエンドユーザー

第7章 地域と国の分析

  • 世界の咽頭炎治療市場、地域別、実績と予測、2018～2023年、2023～2028年、2033年
  • 世界の咽頭炎治療市場、国別、実績と予測、2018～2023年、2023～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 咽頭炎治療市場の競合情勢
  • 咽頭炎治療市場の企業プロファイル
    • Pfizer Inc.
    • GlaxoSmithKline PLC
    • Genentech Inc.
    • Pliva Hrvatska Doo
    • Viatris Inc.

第31章 その他の主要と革新的な企業

  • Teva Pharmaceutical Industries Ltd.
  • AbbVie Inc.
  • Medtronic plc
  • Takeda Pharmaceutical Company Limited
  • Eli Lilly and Company
  • Gilead Sciences Inc.
  • Amgen Inc.
  • Boehringer Ingelheim International GmbH
  • Viatris Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Fresenius Kabi AG
  • Bausch Health Companies Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Dr. Reddy's Laboratories Ltd.
  • Cipla Limited

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の展望と潜在性分析

第36章 付録

目次
Product Code: r12283

“Pharyngitis Treatment Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pharyngitis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharyngitis treatment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The pharyngitis treatment market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Drug Class: Beta Lactams; Macrolides; Cephalosporins; Fluoroquinolones; Tetracycline; Other Drug Classes
  • 2) By Source of Infection: Viral; Bacterial
  • 3) By Modes Of Delivery: Oral; Intravenous; Intramuscular; Other Modes Of Delivery
  • 4) By End-Users: Hospitals; Homecare; Specialty Centers; Other End-Users
  • Companies Mentioned: Pfizer Inc.; GlaxoSmithKline PLC; Genentech Inc.; Pliva Hrvatska D.o.o.; Viatris Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Pharyngitis treatment involves the care and management of individuals who are dealing with inflammation in the oropharynx, commonly referred to as the throat. Pharyngitis can have multiple causes, including bacterial or viral infections, allergies, trauma, malignancy, reflux, and exposure to certain toxins.

The primary classes of drugs used in pharyngitis treatment encompass beta-lactams, macrolides, cephalosporins, fluoroquinolones, tetracyclines, and other categories. Beta-lactams are a class of antibiotics distinguished by the presence of a beta-lactam ring in their chemical structure. Infections can stem from various sources, including viral and bacterial agents. Additionally, treatments are administered through various modes, such as oral, intravenous, intramuscular, and others, catering to diverse end-users, including hospitals, homecare settings, specialty centers, and more.

The pharyngitis treatment market research report is one of a series of new reports from The Business Research Company that provides pharyngitis treatment market statistics, including pharyngitis treatment industry global market size, regional shares, competitors with a pharyngitis treatment market share, detailed pharyngitis treatment market segments, market trends and opportunities and any further data you may need to thrive in the pharyngitis treatment industry. This pharyngitis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pharyngitis treatment market size has grown strongly in recent years. It will grow from $2.15 billion in 2023 to $2.27 billion in 2024 at a compound annual growth rate (CAGR) of 5.5%. The growth in the historic period can be attributed to high prevalence and growing incidence of flu, rising prevalence of pharyngitis, growing awareness of pharyngitis, increasing access to healthcare, rising disposable incomes.

The pharyngitis treatment market size is expected to see strong growth in the next few years. It will grow to $2.8 billion in 2028 at a compound annual growth rate (CAGR) of 5.3%. The growth in the forecast period can be attributed to adoption of rapid point-of-care tests, demand for personalized medicine, prevalence of antibiotic resistance, rising importance of hand hygiene. Major trends in the forecast period include advancements in research and development of pharyngitis therapies, digital health technologies, telehealth integration, .

The increasing transmission of strep throat is poised to drive the expansion of the pharyngitis treatment market. Strep throat is a contagious bacterial infection primarily affecting the throat and tonsils. Swift and effective treatment of strep throat with antibiotics is crucial for symptom relief, complication prevention, and reducing the risk of spreading the infection to others. For example, as of June 2022, data from the Centers for Disease Control and Prevention, a US-based government agency, reveals an annual occurrence of approximately 14,000 to 25,000 cases of invasive group A strep disease in the United States. Furthermore, strep-related diseases prompt 5.2 million outpatient visits and result in 2.8 million antibiotic prescriptions each year. Thus, the increased transmission of strep throat is a significant driver of growth in the pharyngitis treatment market.

The increasing prevalence of influenza is anticipated to drive the expansion of the pharyngitis treatment market. Influenza, commonly referred to as the flu, is a contagious respiratory illness caused by influenza viruses. Pharyngitis treatment plays a pivotal role in addressing influenza, offering relief from symptoms, including inflammation and irritation of the throat, and focusing on managing allergies while preventing complications like pneumonia and bronchitis. For example, data published by the Centers for Disease Control and Prevention (CDC), a US-based government agency, in May 2023, revealed 9 million cases of flu (influenza) in the United States between 2021 and 2022, resulting in 5,000 recorded deaths. Consequently, the increasing incidence of influenza is a key driver of growth in the pharyngitis treatment market.

The influence of patient non-compliance is impeding the progress of the pharyngitis treatment market during the projected period. Failure by patients to adhere to prescribed treatment protocols can lead to delays in their recovery from pharyngitis, resulting in prolonged illness. This extended period of discomfort and hardship might leave patients unsatisfied with the treatment, potentially generating negative word-of-mouth feedback. For example, as of 2022, research published by the BMJ Publishing Group Ltd., a UK-based publisher, indicates that approximately 30% to 50% of individuals with chronic conditions are believed not to adhere to their prescribed medication regimens. Consequently, the effect of patient non-compliance poses a hindrance to the growth of the pharyngitis treatment market.

The prominent companies in the pharyngitis treatment market are introducing innovative products as part of their strategy to maintain their market position. For example, in a notable development, RB Health (US) LLC, a pharmaceutical company based in the United States, unveiled the Mucinex InstaSoothe product line in November 2021. This product line comprises lozenges and sprays engineered to provide relief from sore throat discomfort, also referred to as pharyngitis. The range includes clinically validated sore throat and soothing comfort lozenges, sore throat and cough relief lozenges, and Mucinex InstaSoothe sore throat and pain relief spray. These lozenges are crafted with natural honey and contain 2.4 mg of hexylresorcinol, delivering rapid relief for up to 2 hours. The spray features benzocaine and menthol, offering temporary pain relief and throat soothing properties.

In July 2021, Verfora, a pharmaceutical company headquartered in Switzerland, successfully completed the acquisition of Spagyros Ltd., with the transaction's financial details remaining undisclosed. This strategic move by Verfora is aimed at bolstering its pharmacy and drugstore offerings with a range of products that necessitate in-depth consultations, ultimately reinforcing the company's position in the Swiss consumer healthcare market. Spagyros Ltd., a Switzerland-based enterprise, specializes in the production of phytotherapy and complementary medicines, including treatments for sore throat ailments.

Major players in the pharyngitis treatment market are Pfizer Inc., GlaxoSmithKline PLC, Genentech Inc., Pliva Hrvatska D.o.o., Viatris Inc., Teva Pharmaceutical Industries Ltd., AbbVie Inc., Medtronic PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Fresenius Kabi AG, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Cipla Limited, Hikma Pharmaceuticals PLC, Lupin Limited, Pliva Hrvatska D.o.o., LivaNova PLC, Genentech Inc.

North America was the largest region in the pharyngitis treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in pharyngitis treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the pharyngitis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pharyngitis treatment market consists of sales of antibiotics, antiviral drugs and antifungal medications. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Pharyngitis Treatment Market Characteristics

3. Pharyngitis Treatment Market Trends And Strategies

4. Pharyngitis Treatment Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Pharyngitis Treatment Market Size and Growth

  • 5.1. Global Pharyngitis Treatment Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Pharyngitis Treatment Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Pharyngitis Treatment Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Pharyngitis Treatment Market Segmentation

  • 6.1. Global Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Beta Lactams
  • Macrolides
  • Cephalosporins
  • Fluoroquinolones
  • Tetracycline
  • Other Drug Classes
  • 6.2. Global Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Viral
  • Bacterial
  • 6.3. Global Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oral
  • Intravenous
  • Intramuscular
  • Other Modes Of Delivery
  • 6.4. Global Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Homecare
  • Speciality Centres
  • Other End-Users

7. Pharyngitis Treatment Market Regional And Country Analysis

  • 7.1. Global Pharyngitis Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Pharyngitis Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Pharyngitis Treatment Market

  • 8.1. Asia-Pacific Pharyngitis Treatment Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Pharyngitis Treatment Market

  • 9.1. China Pharyngitis Treatment Market Overview
  • 9.2. China Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Pharyngitis Treatment Market

  • 10.1. India Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Pharyngitis Treatment Market

  • 11.1. Japan Pharyngitis Treatment Market Overview
  • 11.2. Japan Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Pharyngitis Treatment Market

  • 12.1. Australia Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Pharyngitis Treatment Market

  • 13.1. Indonesia Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Pharyngitis Treatment Market

  • 14.1. South Korea Pharyngitis Treatment Market Overview
  • 14.2. South Korea Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Pharyngitis Treatment Market

  • 15.1. Western Europe Pharyngitis Treatment Market Overview
  • 15.2. Western Europe Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Pharyngitis Treatment Market

  • 16.1. UK Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Pharyngitis Treatment Market

  • 17.1. Germany Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Pharyngitis Treatment Market

  • 18.1. France Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Pharyngitis Treatment Market

  • 19.1. Italy Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Pharyngitis Treatment Market

  • 20.1. Spain Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Pharyngitis Treatment Market

  • 21.1. Eastern Europe Pharyngitis Treatment Market Overview
  • 21.2. Eastern Europe Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Pharyngitis Treatment Market

  • 22.1. Russia Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Pharyngitis Treatment Market

  • 23.1. North America Pharyngitis Treatment Market Overview
  • 23.2. North America Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Pharyngitis Treatment Market

  • 24.1. USA Pharyngitis Treatment Market Overview
  • 24.2. USA Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Pharyngitis Treatment Market

  • 25.1. Canada Pharyngitis Treatment Market Overview
  • 25.2. Canada Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Pharyngitis Treatment Market

  • 26.1. South America Pharyngitis Treatment Market Overview
  • 26.2. South America Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Pharyngitis Treatment Market

  • 27.1. Brazil Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Pharyngitis Treatment Market

  • 28.1. Middle East Pharyngitis Treatment Market Overview
  • 28.2. Middle East Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Pharyngitis Treatment Market

  • 29.1. Africa Pharyngitis Treatment Market Overview
  • 29.2. Africa Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Pharyngitis Treatment Market Competitive Landscape And Company Profiles

  • 30.1. Pharyngitis Treatment Market Competitive Landscape
  • 30.2. Pharyngitis Treatment Market Company Profiles
    • 30.2.1. Pfizer Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. GlaxoSmithKline PLC
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Genentech Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Pliva Hrvatska D.o.o.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Viatris Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Pharyngitis Treatment Market Other Major And Innovative Companies

  • 31.1. Teva Pharmaceutical Industries Ltd.
  • 31.2. AbbVie Inc.
  • 31.3. Medtronic plc
  • 31.4. Takeda Pharmaceutical Company Limited
  • 31.5. Eli Lilly and Company
  • 31.6. Gilead Sciences Inc.
  • 31.7. Amgen Inc.
  • 31.8. Boehringer Ingelheim International GmbH
  • 31.9. Viatris Inc.
  • 31.10. Teva Pharmaceutical Industries Ltd.
  • 31.11. Fresenius Kabi AG
  • 31.12. Bausch Health Companies Inc.
  • 31.13. Sun Pharmaceutical Industries Ltd.
  • 31.14. Dr. Reddy's Laboratories Ltd.
  • 31.15. Cipla Limited

32. Global Pharyngitis Treatment Market Competitive Benchmarking

33. Global Pharyngitis Treatment Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Pharyngitis Treatment Market

35. Pharyngitis Treatment Market Future Outlook and Potential Analysis

  • 35.1 Pharyngitis Treatment Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Pharyngitis Treatment Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Pharyngitis Treatment Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer